30Oct 2022
Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 Years

Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 Years

Docosahexaenoic acid (DHA) is a component of neural tissue. Because its accretion into the brain is greatest during the final trimester of pregnancy, infants born before 29 weeks’ gestation do not receive the normal supply of DHA. A total of 1273 infants underwent randomization in the original trial; of the 656 surviving children who had undergone randomization at the centres included in this follow-up study, 480 (73%) had an FSIQ score available — 241 in the DHA group and 239 in the control group. In infants born before 29 weeks’ gestation who had been enrolled in a trial to assess the effect of DHA supplementation on bronchopulmonary dysplasia, the use of an enteral DHA emulsion until 36 weeks of postmenstrual age was associated with modestly higher FSIQ scores at 5 years of age than control feeding.

  • #gynaecology - ivf

Like

Save

Share